HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activity of iodine-123 metaiodobenzylguanidine in childhood neuroblastoma: lack of relation to tumour differentiation in vivo.

Abstract
Neuroblastoma (NB) tumour cells have a remarkable tendency to differentiate spontaneously or under the influence of certain drugs. It is not clear whether metaiodobenzylguanidine (MIBG) uptake correlates with differentiation of NB cells. In 28 tumours of 26 patients, iodine-123 MIBG uptake in primary NBs was studied in relation to tumour differentiation, tumour size, cell density and degree of necrosis in subsequently resected specimens. Genetic features such as the presence of chromosomal aberrations (1p-deletion and MYCN amplification) and/or P-glycoprotein (mdr-1 gene product) were also evaluated in relation to MIBG uptake. A highly variable and unpredictable intensity of MIBG uptake was observed in primary as well as secondary resected tumours. This intensity did not relate to any of the above-mentioned factors except that there was a trend towards more intense uptake with increasing size of the tumour. We conclude from our observations that, in contrast to commonly held opinion, well-differentiated tumours do not a priori show a lower MIBG uptake in vivo, even when there are a low number of viable cells and a high degree of necrosis. The degree of differentiation or tumour viability and necrosis following longstanding chemotherapeutic treatment cannot be predicted by the MIBG scan findings. The observed MIBG uptake may be importantly influenced by factors other than those associated with cellular differentiation.
AuthorsB Brans, G Laureys, V Schelfhout, C V Wiele, C R Potter, C Dhooge, M Simons, R A Dierckx
JournalEuropean journal of nuclear medicine (Eur J Nucl Med) Vol. 25 Issue 2 Pg. 144-9 (Feb 1998) ISSN: 0340-6997 [Print] Germany
PMID9473262 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Iodine Radioisotopes
  • Radiopharmaceuticals
  • 3-Iodobenzylguanidine
Topics
  • 3-Iodobenzylguanidine
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 (analysis)
  • Abdominal Neoplasms (chemistry, diagnostic imaging, genetics, pathology)
  • Adolescent
  • Adrenal Gland Neoplasms (chemistry, diagnostic imaging, genetics, pathology)
  • Cell Count
  • Child
  • Child, Preschool
  • Chromosome Aberrations
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Iodine Radioisotopes
  • Male
  • Necrosis
  • Neoplasm Staging
  • Neuroblastoma (chemistry, diagnostic imaging, genetics, pathology)
  • Predictive Value of Tests
  • Radionuclide Imaging
  • Radiopharmaceuticals
  • Thoracic Neoplasms (chemistry, diagnostic imaging, genetics, pathology)
  • Uterine Cervical Neoplasms (chemistry, diagnostic imaging, genetics, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: